The reported statements, read against the company's own industry.
Financials view
Market Capitalization
8.32BCNY
1.25B · vs all stocks (USD)
Updated Oct 23, 2026
Trailing P/E
199.56x
Updated Oct 23, 2026
Revenue (TTM)
1.13BCNY
169.63M · vs all stocks (USD)
Updated Oct 23, 2026
Profit Margin
3.16%
Updated Oct 23, 2026
Beta
1.34x
vs all stocks
Updated Oct 23, 2026
52-Week Change
147.10%
vs all stocks
Updated Oct 23, 2026
Market Capitalization
8.32BCNY
1.25B · vs all stocks (USD)
Updated Oct 23, 2026
Enterprise Value
7.04BCNY
1.05B · vs all stocks (USD)
Updated Oct 23, 2026
Trailing P/E
199.56x
Updated Oct 23, 2026
Forward P/E
23.03x
Updated Oct 23, 2026
Price to Sales (TTM)
6.74x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 7.35×.Updated Oct 23, 2026
Price to Book (MRQ)
5.94x
Updated Oct 23, 2026
Enterprise to Revenue
6.21x
Updated Oct 23, 2026
Enterprise to EBITDA
98.91x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 73.69×.Updated Oct 23, 2026
Gross Margin
68.91%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 58.96%.Updated Oct 23, 2026
Profit Margin
3.16%
Updated Oct 23, 2026
Operating Margin
4.38%
Updated Oct 23, 2026
Return on Assets (TTM)
1.64%
Updated Oct 23, 2026
Return on Equity (TTM)
3.18%
Updated Oct 23, 2026
Revenue (TTM)
1.13BCNY
169.63M · vs all stocks (USD)
Updated Oct 23, 2026
Revenue per Share (TTM)
2.87CNYUpdated Oct 23, 2026
Quarterly Revenue Growth
-0.50%
Updated Oct 23, 2026
Gross Profit (TTM)
667.68MCNY
100.02M · vs all stocks (USD)
Updated Oct 23, 2026
EBITDA (TTM)
95.49MCNY
14.30M · vs all stocks (USD)
Updated Oct 23, 2026
Net Income (TTM)
35.77MCNY
5.36M · vs all stocks (USD)
Updated Oct 23, 2026
Quarterly Earnings Growth (YoY)
94.90%
Updated Oct 23, 2026
Operating Cash Flow (TTM)
135.77MCNY
20.34M · vs all stocks (USD)
Updated Oct 23, 2026
Levered Free Cash Flow (TTM)
99.87MCNY
14.96M · vs all stocks (USD)
Updated Oct 23, 2026
5-Year Average Dividend Yield
2.76%
vs all stocks
Updated Oct 23, 2026
Payout Ratio
0.00%
Updated Oct 23, 2026
Minority Interest (Equity)
21.85MCNYFY2025 · Dec 31, 2025
Revenue
1.15BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
458.03MCNYFY2025 · Dec 31, 2025
Gross Profit
690.49MCNYFY2025 · Dec 31, 2025
Operating Income
45.60MCNY
6.83M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
17.35MCNYFY2025 · Dec 31, 2025
Income Tax Expense
2.30MCNYFY2025 · Dec 31, 2025
Net Income
15.05MCNYFY2025 · Dec 31, 2025
EBIT
28.98MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
95.49MCNYFY2025 · Dec 31, 2025
Research & Development
28.55MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
329.01MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
16.62MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
2.77MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
11.63MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.0400CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.0400CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
362.97MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
362.97MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
15.05MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-532.83KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
83.08MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-11.83MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
160.39MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
15.05MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
33.36MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
17.99MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
16.68MCNYFY2025 · Dec 31, 2025
Capital Expenditures
94.90MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-1.35BCNYFY2025 · Dec 31, 2025
Sale of Investments
1.36BCNYFY2025 · Dec 31, 2025
Other Investing Activity
-95.00MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
9.04MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
110.00MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-242.00MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-9.68MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-23.09MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-164.77MCNYFY2025 · Dec 31, 2025
Shares Outstanding
425.03MSharesUpdated Oct 23, 2026
Float Shares
224.23MSharesUpdated Oct 23, 2026
% Held by Insiders
33.43%
vs all stocks
Updated Oct 23, 2026
% Held by Institutions
1.42%
vs all stocks
Updated Oct 23, 2026
Total Cash (MRQ)
493.61MCNY
73.94M · vs all stocks (USD)
Updated Oct 23, 2026
Total Cash per Share (MRQ)
1.26CNYUpdated Oct 23, 2026
Total Debt (MRQ)
115.91MCNY
17.36M · vs all stocks (USD)
Updated Oct 23, 2026
Total Debt to Equity (MRQ)
0.0958x
Updated Oct 23, 2026
Current Ratio (MRQ)
3.67x
Updated Oct 23, 2026
Book Value per Share (MRQ)
3.02CNYUpdated Oct 23, 2026
Total Assets
1.53BCNY
229.06M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
837.35MCNYFY2025 · Dec 31, 2025
Total Liabilities
414.89MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
691.77MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
114.28MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
300.61MCNYFY2025 · Dec 31, 2025
Cash
404.62MCNYFY2025 · Dec 31, 2025
Cash Equivalents
5.50MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
410.12MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
80.64MCNYFY2025 · Dec 31, 2025
Accounts Receivable
79.54MCNYFY2025 · Dec 31, 2025
Inventory
221.35MCNYFY2025 · Dec 31, 2025
Accounts Payable
84.40MCNYFY2025 · Dec 31, 2025
Short-term Debt
115.26MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
17.15MCNYFY2025 · Dec 31, 2025
Long-term Debt
110.44MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
419.72MCNYFY2025 · Dec 31, 2025
Retained Earnings
-312.95MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.11BCNY
166.91M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
140.92MCNYFY2025 · Dec 31, 2025
52-Week Low
6.87CNYUpdated Oct 23, 2026
52-Week High
29.30CNYUpdated Oct 23, 2026
52-Week Change
147.10%
vs all stocks
Updated Oct 23, 2026
Beta
1.34x
vs all stocks
Updated Oct 23, 2026
50-Day MA
19.81CNYUpdated Oct 23, 2026
200-Day MA
16.56CNYUpdated Oct 23, 2026
Avg 10-Day Volume
9.55MSharesUpdated Oct 23, 2026
Avg 30-Day Volume
12.44MSharesUpdated Oct 23, 2026
Diluted EPS (TTM)
0.0900CNYUpdated Oct 23, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
It can cover near-term bills from cash alone, not just from inventory.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.69Profit Margin: 0.03
Financial Health
Altman Z-Score 12.98: safe zoneNotable
Altman Z-Score: 12.98
Supply Chain
Upstream position: supplies 5 industries, depends on 2Notable
Outgoing: 5.00Incoming: 2.00
Scale
Market cap is $1.25B, above the global median of $1.14BNotable
Market cap (USD): 1,246,011,071.067Global Median: 1,137,180,293.291
Companies that share the same coordination system — how they create, deliver, or capture value.